Manuel Hermosilla : Citation Profile


Are you Manuel Hermosilla?

Johns Hopkins University

3

H index

1

i10 index

36

Citations

RESEARCH PRODUCTION:

2

Articles

5

Papers

1

Chapters

RESEARCH ACTIVITY:

   11 years (2009 - 2020). See details.
   Cites by year: 3
   Journals where Manuel Hermosilla has often published
   Relations with other researchers
   Recent citing documents: 12.    Total self citations: 3 (7.69 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/phe632
   Updated: 2020-10-17    RAS profile: 2020-05-19    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Manuel Hermosilla.

Is cited by:

Engel, Eduardo (7)

Lasio, Laura (3)

Balmaceda, Felipe (3)

Dubois, Pierre (3)

Escobar, Juan (3)

Fischer, Ronald (2)

Dranove, David (1)

Dethier, Jean-Jacques (1)

Carey, Colleen (1)

Danau, Daniel (1)

Sanzenbacher, Geoffrey (1)

Cites to:

Henderson, Rebecca (5)

Acemoglu, Daron (5)

Sood, Neeraj (5)

Cockburn, Iain (5)

de Mouzon, Olivier (4)

Dubois, Pierre (4)

Dranove, David (4)

Linn, Joshua (4)

Gans, Joshua (3)

Cerda, Rodrigo (3)

Blume-Kohout, Margaret (3)

Main data


Where Manuel Hermosilla has published?


Recent works citing Manuel Hermosilla (2020 and 2019)


YearTitle of citing document
2020Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1.

Full description at Econpapers || Download paper

2019Soft budgets and endogenous renegotiations in transport PPPs: An equilibrium analysis. (2019). Engel, Eduardo ; Galetovic, Alexander ; Fischer, Ronald ; Ra, Eduardo M. In: Economics of Transportation. RePEc:eee:ecotra:v:17:y:2019:i:c:p:40-50.

Full description at Econpapers || Download paper

2020Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D. (2020). Sanzenbacher, Geoffrey ; Wettstein, Gal. In: Journal of Health Economics. RePEc:eee:jhecon:v:72:y:2020:i:c:s0167629619305703.

Full description at Econpapers || Download paper

2020Risk Allocation in Unsolicited and Solicited Road Public-Private Partnerships: Sustainability and Management Implications. (2020). Flores, Diego ; Mesa, Harrison ; Guevara, Jose ; Castelblanco, Gabriel. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:11:p:4478-:d:365893.

Full description at Econpapers || Download paper

2020Dynamic Innovation Strategy Model in Practice of Innovation Leaders and Followers in CEE Countries—A Prerequisite for Building Innovative Ecosystems. (2020). Prokop, Viktor ; Striteska, Michaela Kotkova. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:9:p:3918-:d:356687.

Full description at Econpapers || Download paper

2019The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals. (2019). Kyle, Margaret K. In: NBER Chapters. RePEc:nbr:nberch:14260.

Full description at Econpapers || Download paper

2019The Opportunities and Limitations of Monopsony Power in Healthcare: Evidence from the United States and Canada. (2019). Dranove, David ; Keener, Jordan ; Garthwaite, Craig ; Chown, Jillian. In: NBER Working Papers. RePEc:nbr:nberwo:26122.

Full description at Econpapers || Download paper

2020Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination. (2020). Wasserman, Melissa F ; Frakes, Michael D. In: NBER Working Papers. RePEc:nbr:nberwo:27579.

Full description at Econpapers || Download paper

2020Innovation, Competition, and Incomplete Adoption of a Superior Technology. (2020). Sandrini, Luca. In: Marco Fanno Working Papers. RePEc:pad:wpaper:0251.

Full description at Econpapers || Download paper

2019Patents, Data Exclusivity, and the Development of New Drugs. (2019). Wagner, Stefan ; Gaessler, Fabian. In: Rationality and Competition Discussion Paper Series. RePEc:rco:dpaper:176.

Full description at Econpapers || Download paper

2020Marketing research in China during the 40-year reform and opening. (2020). Wang, Yonggui ; Hu, YU. In: Frontiers of Business Research in China. RePEc:spr:fobric:v:14:y:2020:i:1:d:10.1186_s11782-019-0071-0.

Full description at Econpapers || Download paper

2020Emerging market innovations: unique and differential drivers, practitioner implications, and research agenda. (2020). Shankar, Venkatesh ; Narang, Unnati. In: Journal of the Academy of Marketing Science. RePEc:spr:joamsc:v:48:y:2020:i:5:d:10.1007_s11747-019-00685-3.

Full description at Econpapers || Download paper

Works by Manuel Hermosilla:


YearTitleTypeCited
2009Renegociación de concesiones en Chile In: Documentos de Trabajo.
[Full Text][Citation analysis]
paper20
2018Market size and innovation: The intermediary role of technology licensing In: Research Policy.
[Full Text][Citation analysis]
article2
2018Therapeutic Translation of Genomic Science: Opportunities and Limitations of GWAS In: NBER Chapters.
[Full Text][Citation analysis]
chapter1
2017Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS.(2017) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 1
paper
2014Pharmaceutical Profits and the Social Value of Innovation In: NBER Working Papers.
[Full Text][Citation analysis]
paper7
2020Expected Profits and The Scientific Novelty of Innovation In: NBER Working Papers.
[Full Text][Citation analysis]
paper1
2019Structural Models of the Prescription Drug Market In: Foundations and Trends(R) in Marketing.
[Full Text][Citation analysis]
article3
2017Can Emerging Markets Tilt Global Product Design? Impacts of Chinese Colorism on Hollywood Castings In: MPRA Paper.
[Full Text][Citation analysis]
paper2

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated October, 6 2020. Contact: CitEc Team